Attralus logo
VerifiedBiotechnology Research

Attralus

Attralus is a clinical stage biopharmaceutical company focused on creating transformative medicines to improve the lives of patients with systemic amyloidosis. Our proprietary pan-amyloid removal (PAR) therapeutics are designed to directly bind to and remove toxic amyloid in organs and tissues. By targeting the universal disease-causing pathology in all systemic amyloidosis diseases, PAR therapeutics have the potential to treat and reverse disease in patients with all types and stages of systemic amyloidosis.

7-day free trial · no credit card

HeadquartersNaples, United StatesEmployees23(11 to 50)Annual revenue$1M to <$10MWebsiteattralus.comLinkedIn profileLinkedIn

Verified contacts

23

available on Kipplo

LinkedIn employees

23

11 to 50 range

Open roles

no listings

Distinct roles

17

indexed titles

Tech stack

2

tools in use

Monthly traffic

99

organic / mo

Sign up free to see all 23 verified contacts at Attralus

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

23 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Attralus

17 distinct titles indexed · top 10 shown.

  • 3, -
  • 1board member
  • 1director of biology
  • 1director of biology, research and development, cns diseases
  • 1director of clinical operations
  • 1director of manufacturing and process development
  • 1director of quality
  • 1gmp quality manager
  • 1head of it operations
  • 1head of program management
  • +7more titles

Sign up to unlock all 23 contacts at Attralus

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 23 verified contacts at Attralus

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Attralus | Kipplo Discover